Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
43,519,167
-
Share change
-
-2,526,816
-
Total reported value
-
$3,274,819,662
-
Put/Call ratio
-
239%
-
Price per share
-
$75.25
-
Number of holders
-
200
-
Value change
-
-$39,110,151
-
Number of buys
-
133
-
Number of sells
-
89
Institutional Holders of TURNING POINT THERAPEUTICS I - COM (TPTX) as of Q2 2022
As of 30 Jun 2022,
TURNING POINT THERAPEUTICS I - COM (TPTX) was held by
200 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,519,167 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Cormorant Asset Management, LP, ORBIMED ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, FIL Ltd, FARALLON CAPITAL MANAGEMENT LLC, ALPINE ASSOCIATES MANAGEMENT INC., and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
200
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.